Hypertensive nephropathy classification: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
* Malignant (accelerated) arteriolar nephrosclerosis | * Malignant (accelerated) arteriolar nephrosclerosis | ||
** Characterized by sudden elevation of [[blood pressure]] ([[diastolic pressure]] > 130 mm Hg) along with [[papilledema]], central nervous system manifestations like [[confusion]], cardiac decompensation and acute progressive decline in renal function. | ** Characterized by sudden elevation of [[blood pressure]] ([[diastolic pressure]] > 130 mm Hg) along with [[papilledema]], central nervous system manifestations like [[confusion]], cardiac decompensation and acute progressive decline in renal function. | ||
==References== | |||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 03:04, 27 September 2012
|
Hypertensive nephropathy Microchapters |
|
Differentiating Hypertensive Nephropathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hypertensive nephropathy classification On the Web |
|
American Roentgen Ray Society Images of Hypertensive nephropathy classification |
|
Risk calculators and risk factors for Hypertensive nephropathy classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]
Overview
Classification
Hypertensive nephropathy is divided into two distinct entities:
- Benign arteriolar nephrosclerosis
- Seen in patients who are hypertensive for a long period of time (> 150/90 mm Hg) but has not progressed to malignant stage.
- Malignant (accelerated) arteriolar nephrosclerosis
- Characterized by sudden elevation of blood pressure (diastolic pressure > 130 mm Hg) along with papilledema, central nervous system manifestations like confusion, cardiac decompensation and acute progressive decline in renal function.